Training session for patients and consumers involved in European Medicines Agency activities

• Date:
  Tuesday, 25 November 2014
• Location:
  European Medicines Agency, Amsterdam, the Netherlands

This is a training session for patients' and consumers' organisations involved in European Medicines Agency activities. Topics to be presented include an overview of the Agency and the centralised procedure, as well as how patients are involved in scientific advice, scientific-advisory-group (SAG) meetings, the review of information to patients and pharmacovigilance. Registration by invitation only.

Documents

Agenda - Training session for patients and consumers involved in European Medicines Agency activities

DraftReference Number: EMA/632556/2014

List of Participants - Training session for patients and consumers involved in EMA activities

Reference Number: EMA/702994/2014

Presentation - Objectives of the training

Presentation - How are medicines evaluated at EMA (Nathalie Bere)

Presentation - Scientific advice/protocol assistance and patients (Francesca Cerreta)

Presentation - Scientific Advisory Groups (SAG) - Experience and impact of patient involvement (Francesco Pignatti)

Presentation - What is a package leaflet – How to review it? (Claire Espinasse)

Presentation - EPAR summaries - Introduction to review by patients and consumers (Paul Blake)

Presentation - What are safety communications and how to review them (Federica Castellani)

Presentation - What is Pharmacovigilance for patients (Priya Bahri)

Presentation - e-DoI and e-CV submission: Why – Who – What – How? (Luc Van Santvliet)

Multimedia